Overexpression of METTL14 has increased the levels of AST, ALT, TG, TC, pro-inflammatory factors, and lipid accumulation, thereby promoting chronic inflammation and cellular apoptosis, typical features of NAFLD [10]. This evidence concerns the gene METTL14 and metabolic dysfunction-associated steatotic liver disease.